PMV Pharmaceuticals, Inc.
SEC CIK 1699382 · PMVP · last insider filing 2026-06-05
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Levine Arnold J | Director | filed 2020 - 2026 |
| Gallagher Carol Giltner | Director | filed 2022 - 2026 |
| Baum Charles M | Director | filed 2021 - 2026 |
| Stelzer Laurie | Director | filed 2020 - 2026 |
| Flowers Kirsten | Director | filed 2022 - 2026 |
| Mack David Henry | Director · President and CEO | filed 2020 - 2026 |
| Orbimed Advisors LLC | Director | filed 2020 - 2025 |
| Orbimed Capital GP V LLC | Director | filed 2020 - 2025 |
| Heyman Richard A. | Director | filed 2020 - 2025 |
| Orbimed Genesis GP LLC | Director | filed 2020 - 2023 |
| Orbimed Capital LLC | Director | filed 2020 - 2022 |
| Schroeder Thilo | Director | filed 2020 - 2021 |
| Thompson Peter A. | Director | filed 2020 - 2021 |
| Oronsky Arnold L | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Ticktin Robert | General Counsel & COO | filed 2025 - 2026 |
| Jalota Deepika | SVP, Regulatory Affairs and QA | filed 2020 - 2026 |
| Carulli Michael | Chief Financial Officer | filed 2024 - 2026 |
| Alland Leila | Chief Medical Officer | filed 2020 - 2023 |
| Kung Winston | COO, CFO | filed 2020 - 2023 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.